Companies Cryptocurrencies
IMV Inc
IMV Inc
Exchange: NasdaqCM
IPO Date: 24/10/2007
CEO: Mr. Frederic Ors
Biotechnology Healthcare đź”—
  • IMV
    symbol
  • 3.21
    price
  • 214677424
    market cap
  • -0.02
    changes
If you bought

shares of IMV Inc (IMV) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

IMV, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of immunotherapies for the treatment of infectious diseases. The company is headquartered in Dartmouth, Nova Scotia and currently employs 51 full-time employees. The Company’s drug delivery platform (DPX) enables the programming of immune cells in vivo. The Company’s lead candidate, DPX-Survivac, is a T cell-activating immunotherapy combining DPX with a specific tumor target: Survivin. DPX-Survivac is a monotherapy in ovarian cancer and in combination with Merck’s Keytruda across multiple cancer indications.

Address: 130 Eileen Stubbs Ave Suite 19 Dartmouth NOVA SCOTIA B3B 2C4

Stay updated.